Printable PDF - Tessenderlo Group

‘The acquisition of the two American units has made Tessenderlo Group a fullyfledged
global operator on the gelatin market. Although both factories only
belonged to the group for nine months, they made a significant contribution
to the results in 2003, which is an outstanding performance.’
Natural Organic Products Turnover
(millions EUR)
– Pharmaceutical and parapharmaceutical industries: for the production of hard and soft capsules;
– Photography: gelatin is used to bind the photoactive silver compounds, and used as well in the various
layers of films, photographical paper and paper of inkjet printers;
– Micro-encapsulation: microscopic capsules which can contain (for example) ink for photocopying paper,
or vitamins which are mixed in animal feed.
By-products of animal origin
2003 2002
Turnover 313 261
(millions EUR)
Ebitda 57 53
(millions EUR)
Tangible investments 25 32
(millions EUR)
Headcount 1,853 1,547
Through its French subsidiary Caillaud, Tessenderlo Group plays a major role in the collection and treatment
of animal by-products. The annual capacity amounts to 950,000 tonnes.
Caillaud is active in two specific sectors:
94 95 96 97 98 99 00 01 02 03
– As a rendering plant, it handles the collection and treatment of risk waste, which is primarily used as an
energy source by the cement industry. This activity accounts for 36% of the turnover, and is a public
service, for which Caillaud is paid by the French State;
– The valorisation of animal materials, originating from animals that are fit for human consumption, into
• degreased bones for the production of gelatins;
• proteins and animal fats for use in pet food;
• fats for the soap industry and lipochemistry;
• frozen processed animal by-products for the production of ‘moist’ pet food.
350
300
250
200
150
100
50
0
313
47